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Abstract—In previous studies electrically-evoked release of
acetylcholine in septal slices was demonstrated. The present
experiment aimed at verifying if this release involved intrinsic
neurons bearing p75NTR receptors. Long-Evans rats sus-
tained injections of 192 IgG-saporin into the medial septum/
diagonal band of Broca (0.8 g). Sham-operated rats served
as controls. Two to 3.5 weeks later, the electrically-evoked
release of acetylcholine ([3H]ACh) was measured in slices
from the lateral septum (LS), medial septum (MS) and diago-
nal band of Broca (DBB). Choline acetyltransferase (ChAT)
and acetylcholinesterase (AChE) activity, and monoamine
concentrations were measured in the septum, cortex and
hippocampus. The lesion extent was also assessed by ChAT
immunostaining in a separate series of rats. In the septum,
the number of ChAT-positive neurons was depleted dramat-
ically (>90% at the level of the injection site). In the hip-
pocampus, the lesions reduced ChAT and AChE activity by
91% and 84%, respectively. In the cortex, this reduction was
weaker (55% and 47%). In the septal region, the reduction
was either weak or not significant. The evoked release of
acetylcholine in septal slices was not reduced, except in the
slices from the LS (64%). The effects of physostigmine and
atropine confirmed the presence of autoreceptors. Our data
exclude that a major part of the acetylcholine released by MS
and DBB slices derived from intrinsic neurons bearing
p75NTR receptors. In the LS, part of the released acetylcholine
might be from projections of such neurons located in the LS,
MS and/or DBB. These data also suggest that the MS and the
DBB may be the target of extrinsic cholinergic innervation
that does not bear p75NTR receptors. © 2003 IBRO. Published
by Elsevier Ltd. All rights reserved.
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The septal region is a telencephalic structure enclosing the
lateral septum (LS), the medial septum (MS) and both the
vertical and horizontal limbs of the diagonal Band of Broca
(DBB; Jakab and Leranth, 1995). The MS and the DBB
contain cell bodies and dendrites of cholinergic neurons
innervating primarily the hippocampus (e.g. Amaral and
Kurz, 1985; Jakab and Leranth, 1995; Lewis et al., 1967).
In these subregions of the septal area, cholinergic termi-
nals have been described (e.g. Bialowas and Frotscher,
1987). In experiments which focused on the postnatal
development of presynaptic inhibitory muscarinic autore-
ceptors, Disko et al. (1998, 1999) previously measured the
electrically-evoked release of acetylcholine (ACh) in septal
slices and, among other results, showed that it was par-
ticularly important in the MS and the DBB and represented
action potential-evoked exocytosis. Comparable findings
based on microdialysis experiments were reported in the
basal forebrain, but without paying attention to any given
structure of this brain region (Consolo et al., 1990). One
important and yet unresolved question raised by Disko et
al. (1999) concerns the origin of the ACh released by
septal slices. Indeed, this ACh may have derived from the
i) locally projecting axon terminals or collaterals of septal
cholinergic neurons [e.g. Ha¨ge et al., 1996; locally project-
ing collaterals have been described by Brauer et al.
(1998)], ii) cell bodies and dendrites of septal cholinergic
neurons (as shown, for instance, for dopaminergic neurons
in the substantia nigra: Geffen et al., 1976), or iii) afferents
from cholinergic neurons located outside the septum (e.g.
pedunculopontine and dorsolateral nuclei which both
project to the LS; Jakab and Leranth, 1995).
While most cholinergic neurons of the septal region
express p75NTR receptors, the low affinity receptors for
nerve growth factor, those of other cholinergic nuclei not
located in the basal forebrain do not bear such receptors
(e.g. Heckers et al., 1994; Torres et al., 1994). Interest-
ingly, these receptors are the target of an immunotoxin,
192 IgG-saporin (e.g. Wrenn and Wiley, 1998), which en-
ables selective and massive damage to cholinergic neu-
rons of the basal forebrain bearing such receptors. There-
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fore, if the evoked release of ACh in septal slices was
mainly based on a somatodendritic exocytotic mechanism
or originated from a local, intraseptal network (of e.g. col-
laterals of cholinergic axons) arising from neurons ex-
pressing p75NTR receptors, it may be assumed that rats
subjected to 192 IgG-saporin lesions should show a more
or less dramatic decrease of this release. In order to test
this hypothesis, the present experiment aimed at investi-
gating the electrically-evoked release (and its inhibition by
autoreceptors) of ACh in rats subjected to intraseptal in-
jections of 192 IgG-saporin. Furthermore, as Disko et al.
(1999) showed that the amount of ACh release was not
homogeneous over the entire septal region, slices from




Chemicals and drugs were obtained from the following sources:
[1-14C]-acetyl coenzyme A (52 mCi/mmol) and [methyl-3H]choline
chloride (82 Ci/mmol) from Amersham-Pharmacia, Freiburg, Ger-
many; hemicholinium-3 from Chemcon, Freiburg, Germany; cho-
line bromide, acetyl coenzyme A, acetylthiocholine iodide, atro-
pine sulfate, physostigmine hemisulphate from Sigma Aldrich
Chemie GmbH, Steinheim, Germany.
Subjects
All procedures involving animals and their care were conducted in
conformity with the international guidelines that are in compliance
with national (Council directive 87848, October 19, 1987, Minis-
te`re de l’Agriculture et de la Foreˆt, Service Ve´te´rinaire de la Sante´
et de la Protection Animales; permission 6212 to J.-C.C. and
6714-bis to H.J.) and international (NIH publication 80–23, revised
1996) laws and policies. All efforts were made to minimize animal
suffering and to keep the number of animals used as low as
possible regarding statistical constraints.
The study used 32 male Long-Evans rats aged of 3 months
and weighing 2706.4 g at the time of surgery. They were housed
individually in transparent Makrolon cages (422615 cm) under
a 12-h light/dark cycle (lights on at 7:00 h), with ad libitum access
to food and water. The colony and testing rooms were under
controlled temperature (21 °C).
Surgery
All surgical procedures were performed under aseptic conditions,
using anesthesia by a mixture of ketamine and xylazine (6.38 and
0.85 mg/kg, respectively, i.p.). Sixteen rats (Group SAPO-SPT)
were subjected to an injection into the MS and DBB of 0.8 g of
192 IgG-saporin (in 0.68 L of phosphate-buffered saline [PBS];
ATS, San Diego, CA, USA). The injections were performed ster-
eotaxically through a 2 l Hamilton syringe according to coordi-
nates of the Paxinos and Watson (1986) brain atlas. Coordinates
were (in mm from Bregma): AP0.6, ML0.2, DV7.2
(0.17 g/0.2 L/site), and AP0.6, ML0.2, DV6.5
(0.17 g/0.2 L/site). From a recent experiment we know that
these coordinates and this amount of 192 IgG-saporin enable the
destruction of almost all choline acetyltransferase (ChAT)-positive
neurons in the MS and the vertical limb of the DBB (Lehmann et
al., 2003) and abolish almost all hippocampal acetylcholinester-
ase (AChE)-positive staining (Lehmann et al., 2002b). The incisor
bar was set at the level of the interaural line. On each site, the
needle was left in situ after each injection for 6 min before being
retracted slowly. Sixteen rats received sham injections of PBS and
were used as controls (Group SHAM).
Electrically-evoked [3H]acetylcholine overflow
Starting from 2 weeks after surgery, the rats for the superfusion
experiments (six SAPO-SPT and six SHAM) were used within a
period of 10 days. They were killed by decapitation, their brain
was quickly removed and the septal region was dissected out
as described previously (Disko et al., 1999) with one modifica-
tion: before being sliced, the most ventral part of the septal
piece, i.e. mainly the islands of Calleja and olfactory tubercles
(Paxinos and Watson, 1986), was cut away and discarded.
Then, the remaining tissue was cut along the dorsoventral axis
(horizontal plane) in slices of 300 m using a McIlwain tissue
chopper. This dissection method enabled separation of slices
including the LS, the MS or the DBB as reported by Disko et al.
(1999), but also in accordance with the dorsoventral position of
these regions in Ha¨ge et al. (1996). Thus, slices comprising the
LS (the first 1.5 mm; LS; i.e. between corpus callosum and A on
Fig. 1), the MS (the next 1.5 mm; MS; i.e. between A and B on
Fig. 1), and the DBB (the last 1.7 mm; DBB; i.e. between B and
the ventral limit of the brain in Fig. 1; but notice that, in addition,
the islands of Calleja and the olfactory tubercles found in the
most ventral portion of this preparation were discarded) were
incubated separately in wells containing 2 ml of a modified
Krebs-Henseleit (KH) buffer with [3H]choline (0.1 M) for 45 min
at 37 °C under carbogen. The KH solution had the following
composition (in mM): NaCl, 118; KCl, 4.8; CaCl2, 1.3; MgSO4, 1.2;
NaHCO3, 25; KH2PO4, 1.2; glucose, 10; ascorbic acid, 0.6;
Na2EDTA, 0.03; saturated with carbogen, pH adjusted to 7.4.
From each region, the largest slices were cut at the level of the
midline to obtain two pieces. Thus, about eight to 11 slices could
be obtained from each septal subregion. After incubation, the
slices were washed three times with KH buffer, transferred into
superfusion chambers (one slice per chamber) and superfused
with oxygenated KH buffer (37 °C) at a rate of 1.2 ml/min. The
superfusion medium was supplemented routinely with hemicho-
linium-3 (10 M). Fractions (2 min) to be measured were collected










Fig. 1. Delimitations of the septal subregions for counting of ChAT-
positive neurons. Drawing according to Paxinos and Watson (1986) at
Bregma0.2 mm. Hatched lineslimits of the septal area as indicated
in the atlas. Stippled line A: ventral limit of the LS and dorsal limit of the
MS (the dorsal limit of the LS was the corpus callosum, abbreviated
CC); stippled line B: ventral limit of the MS and dorsal limit of the vDBB;
stippled line C: ventral limit of the vDBB and dorsal limit of the hDBB;
continuous lines D and E: lateral limits of the hDBB. For the superfu-
sion experiments, the DBB consisted in a piece of septal tissue includ-
ing the vDBB and the hDBB (dorsal limitB).
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The release of [3H]ACh was induced by electrical field stim-
ulations (360 rectangular pulses at 3 Hz, 2 ms, 4 V/chamber,
26–28 mA) after 34 min (S1), 50 min (S2) and 68 min (S3) of
superfusion. Drugs to be tested (physostigmine 1 M, physostig-
mine 1 Matropine 1 M) were added to the superfusion me-
dium of some chambers from 8 min before the second or third
stimulation onwards. At the end of the experiment (i.e. after 76 min
of superfusion), the radioactivity of superfusate samples and
slices (dissolved in 300 l Solvable 350; Packard, Frankfurt, Ger-
many) was determined by liquid scintillation counting. The frac-
tional rate of tritium outflow (in percent of tissue tritium per min)
was calculated as: (pmoles tritium outflow per min)100/
2(pmoles tritium in the slice at the start of the corresponding
2-min period). The basal tritium outflow in the fraction preceding
S1 is given either in absolute terms (nCi [
3H]outflow per 2 min) or
in relative terms (fractional rate of tritium outflow per 2 min). The
stimulation-evoked overflow of tritium was calculated by subtrac-
tion of the basal outflow and is shown either in absolute terms (nCi
[3H]overflow) or in relative terms (in percent of the tritium content
of the slice at the onset of the respective stimulation period).
Effects of drugs added before S2 and S3 (8 min before in each
case) were determined as the ratio of the overflow evoked by the
corresponding stimulation period (S2/S1, S3/S1) and compared
with the appropriate control ratio (no drug addition before S2 or
S3). Physostigmine (1 M) was added before S2 and atropine
(1 M), in addition to physostigmine (1 M), was added before
S3.
Monoamine concentrations, ChAT and AChE activity
in rats used for superfusion experiments
Monoamine concentrations, ChAT and AChE activity were de-
termined in homogenates prepared from part of the frontopari-
etal cortex and the hippocampus of the rats used for superfu-
sion experiments. Once dissected out from the brain, the hip-
pocampal and cortical tissues were homogenized separately in
1 ml 0.32 M sucrose (in 2.5 mM HEPES, pH 7.4) in a Potter
Elvehjem glass/teflon homogenizer (8 strokes at 500 r.p.m.).
From this crude homogenate, a 20 l sample was diluted with
180 l 0.1 N NaOH and used for measurement of protein
according to Lowry et al. (1951). A 300 l aliquot was mixed
with 300 l of 0.2 N HClO4 (containing 250 mg Na2SO3 and 200
mg disodium EDTA per liter) and stored at 80 °C until deter-
mination of noradrenaline (NA), serotonin (5-HT), 5-hydroxyin-
dole acetic acid (5-HIAA), dopamine (DA) and dihydroxyphenyl
acetic acid (DOPAC) by high-performance liquid chromatogra-
phy (HPLC) with electrochemical detection as described previ-
ously (Birthelmer et al., 2003b,c). Two 100 l samples of the
homogenate were stored at 80 °C until determination of ChAT
and AChE activity according to Fonnum (1975) and Ellman et
al. (1961), respectively, as described in detail previously
(Birthelmer et al., 2003b,c). As the release experiments neces-
sitated all slices prepared from the septal region, it was not
possible to measure the activity of both enzymes or to perform
immunostaining in the septal region of the rats used in the
superfusion experiments. In these rats, the lesion extent was
measured by the reduction of ChAT and AChE activity in the
hippocampus, an approach legitimated by the fact that the
cholinergic innervation of the hippocampus originates in the
septal region, and that most neurons of this region project to the
hippocampus (Sofroniew et al., 1987).
ChAT and AChE activity in a separate set of rats not
used for superfusion experiments
Because ChAT and AChE activity could not be determined in the
septal region of the rats used for superfusion experiments or those
used for immunostaining, an additional set of SHAM (n6) and
SAPO-SPT (n6) rats was killed by decapitation 2 weeks after
lesion surgery. Homogenates were prepared from the LS, the MS
and the DBB, as well as from the hippocampus and the frontopa-
rietal cortex. Measurements of the activity of ChAT and AChE
were made as described above.
ChAT immunostaining in the septal region
In four SAPO-SPT and four SHAM rats we further assessed the
adequacy, especially in terms of location and extent, of the
cholinergic lesion by ChAT immunostaining in the septal region.
Two weeks after lesion surgery, rats were injected with a lethal
dose of pentobarbital (100 mg/kg, i.p.; CEVA Sante´ Animale,
Libourne, France) and transcardially perfused with 60 ml of
0.1 M phosphate-buffered paraformaldehyde (4 °C, pH 8,
10 ml/min). Once extracted, the brains were post-fixed for
approximately 2 h and transferred into a 0.1 M phosphate-
buffered 20% sucrose solution, in which they were kept for
36 – 40 h. The brains were then frozen and cut in sections of
60 m from the anterior septum to the beginning of the dorsal
hippocampus using a cryostat (23 °C). Sections were col-
lected free floating in wells containing cryoprotectant. Every
fourth section was stained for ChAT (goat polyclonal antibody;
Chemicon International, Temecula, CA, USA) using the avidin–
biotin–peroxidase ABC procedure of Hsu et al. (1981). Briefly,
free floating sections were rinsed several times in PBS (1 M, pH
7.4) before being soaked in 10% normal donkey serum (Dut-
scher, Brumath, France) in PBS with 0.5% Triton X-100 and
20% merthiolate for 1 h. After three PBS rinses, sections were
incubated with the anti-ChAT antibody (1:200) in PBS with
0.5% Triton X-100 and 20% merthiolate at room temperature
for 18 h. Sections were then rinsed three times for 10 min in
PBS before being incubated for 1 h with biotinylated secondary
antibody against goat IgG (1:200; Chemicon International), in
PBS with 0.5% Triton X-100 and 20% merthiolate. After three
washes in PBS, sections were soaked in avidin– biotin–peroxi-
dase complex (1:500; Vectastain Elite ABC; Vector Laborato-
ries, Burlingame, CA, USA) in PBS with 0.5% Triton X-100 and
20% merthiolate for 1 h. Finally, after two PBS and one final
Tris-buffered saline (TBS, pH 7.6) rinses, for 10 min each, the
sections were exposed to a solution of 0.0125% 3,3 diamino-
benzidine in TBS containing 0.025% H2O2 for 30 min. The
sections were then mounted onto gelatin-coated slides, dried,
dehydrated and coverslipped. Omission of the primary antibody
served as negative control and resulted in no detectable
staining.
Anatomical landmarks were used to select, define, and
standardize the location of counting frames of a set size in the
MS and the vertical and horizontal limbs of the DBB (vDBB and
hDBB, respectively). The number of ChAT-positive neurons
was determined in the MS area, which was defined dorsally and
laterally by the distribution of stained neurons and ventrally by
an imaginary line through the center of the anterior commis-
sure. From each rat, three coronal sections were selected: a
section corresponding to the injection site (AP 0.6 mm, iden-
tified by the presence of the cannula track) and two other
sections localized at AP 0.2 mm and AP 1.0 mm. Counts of
labeled neurons were performed at a 200 (10 oculars and
20 objective) magnification. The dorsal limit of the vertical
limb of the vDBB was set at the imagery line joining the centers
of the left and the right anterior commissures. The ventral limit
of the DBB was set at 1 mm below the dorsal one and the lateral
limits were defined by the extent of the distribution of ChAT-
positive neurons. Finally, the region containing the horizontal
limbs of the DBB were delimited as follows: the ventral limit of
the vDBB was also the dorsal limit of the region containing the
hDBB (i.e. line C in Fig. 1), the ventral limits of the brain were
used as ventral limits of this region, and virtual lines prolonging
the lateral limits of the lateral ventricles toward the ventral side
of the brain were used as lateral borders of this region (see
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lines D and E in Fig. 1). There was no hDBB at 1.0 mm anterior
to Bregma.
Statistical analysis
A first analysis compared the values found in each septal
subregion of SHAM rats. Where appropriate, 22 comparisons
used a Newman-Keuls test (N-K hereafter). Data were then
analyzed separately for each subregion using parametric sta-
tistics (analysis of variance [ANOVA]) in order to compare
SHAM and SAPO-SPT rats. One rat from the lesion group used
in superfusion experiments showed an insufficient reduction of
both ChAT and AChE activity and was discarded from the study
(n5 in the corresponding SAPO-SPT group). ANOVA of the
effects of drug application used a Group (SHAM, SAPO-
SPT)Drug (CTRL, DRUG) design. The number of ChAT-pos-
itive neurons detected in the septal region was analyzed using
a t-test. For all these analyses, the null hypothesis was rejected
at P0.05.
RESULTS
ChAT and AChE activity in target regions of basal
forebrain cholinergic neurons (in rats used for
superfusion experiments)
To assess the extent of the cholinergic lesions in the rats
used for superfusion experiments, activity of ChAT and
AChE was measured in the hippocampus and the cortex.
Data are shown in Fig. 2. In the hippocampus, ANOVA
showed a significant Group effect on ChAT (F 1/8199.6,
P0.001) and AChE (F 1/8178.9, P0.001) activity. In
the SAPO-SPT rats, ChAT activity was reduced by 91%
and AChE activity by 83%. In the cortex, ANOVA also
showed a significant Group effect on ChAT (F 1/821.9,
P0.01) and AChE (F 1/839.0, P0.001) activity. ChAT
activity was reduced by 55% and AChE activity by 59%.
ChAT and AChE activity in the LS, MS, DBB,
hippocampus and frontoparietal cortex (in rats not
used for superfusion experiments)
In a set of separate rats, activity of ChAT and AChE was
also determined in homogenates of the LS, MS and
DBB, as well as, once again, in the hippocampus and
frontoparietal cortex to control for the lesion extent in
target regions of the basal forebrain. Data are shown in
Table 1. Analysis of the ChAT or AChE activity in the
three septal subregions of SHAM rats showed a signif-
icant Subregion effect for both enzymes (ChAT: F
2/158.54, P0.01; AChE: F 2/1512.03, P0.001).
Two by two comparisons showed that ChAT activity was
significantly higher in the DBB as compared with either
the LS or the MS (P0.01), and that AChE activity was
significantly higher in the MS as compared with the LS
(P0.01), as well as in the DBB as compared with the
MS (P0.01). When ANOVA considered both experi-
mental groups, there was a significant Group effect on
ChAT activity only in the MS (F 1/1013.07, P0.01).
ANOVA of the ChAT and AChE activity in the hippocam-
pus and the cortex yielded effects comparable to the
ones described above in the rats used for the superfu-
sion experiments (hippocampus: F 1/1077.4 and 75.4
for ChAT and AChE activity, respectively; cortex: F
1/107.71 and 11.0 for ChAT and AChE activity, re-
spectively; P0.05, at least). ChAT activity was de-
creased by 87% in the hippocampus and 52% in the
cortex, while AChE activity was decreased by 90% in the
hippocampus and 51% in the cortex.
ChAT immunostaining (in a set of rats not used for
superfusion experiments)
As illustrated in Fig. 3, there was an almost complete loss
of ChAT-positive neurons in the MS and the DBB after
intraseptal injections of 192 IgG-saporin. This was con-
firmed by cell counts, as shown in Table 2. Indeed, the
number of ChAT-positive cells was reduced by 74%, 96%
and 85% at 1.0 mm, 0.6 mm and 0.2 mm anterior to
Bregma, respectively. Similar changes were found in the
vertical and horizontal limbs of the DBB. There was no
hDBB at 1.0 mm anterior to Bregma. All these decreases
were significant at P0.001 (t-test). It is also noteworthy
that there were no AChE-positive reaction products in the
hippocampus of SAPO-SPT rats (data not illustrated).
Accumulation of [3H]choline in septal slices
Data indicated in pmol/slice are shown in Fig. 4. From this
figure it is clear that the accumulation of [3H] was not
comparable among the three septal subregions. Hetero-
geneity of the [3H]choline accumulation was confirmed by
an ANOVA of the data from the three subregions of only
the control group (SHAM). This analysis demonstrated a
significant Subregion effect (F 2/10853.0, P0.001).
Two by two comparisons (N-K) showed that the accumu-
lation of tritium was significantly lower in the LS as com-
pared with the MS (MS, P0.001) or to the DBB (DBB,
P0.001). The difference between the MS and the DBB
was also significant (P0.01).
When ANOVA considered the two experimental
groups, there was a significant Group effect in the LS (F
1/7311.1, P0.01), but neither in the MS (F 1/782.0),
nor in the DBB (F 1/711). In the LS, the accumulation of
[3H]choline was reduced by 21%.
Baseline outflow of tritium
Data are shown in Table 3. ANOVA of the data from the
three septal subregions of SHAM rats showed a significant
Subregion effect on both the absolute (in nCi) and the
relative (in percent of [3H] accumulation) basal outflow of
tritium (F 2/108109.7 and 3.8, respectively, P0.05). On
the absolute outflow, as substantiated by the N-K test, this
effect was due to values that were significantly lower in the
LS as compared with both other subregions (P0.001),
but also in the MS as compared with the DBB (P0.001).
The relative outflow was significantly lower in the MS as
compared with the DBB (P0.01).
When ANOVA considered the absolute outflow of [3H]
in each subregion of both experimental groups, there was
a significant Group effect in the LS (F 1/7318.5,
P0.001), the MS (F 1/7816.8, P0.001), and in the
DBB (F 1/7111.8, P0.01). When ANOVA considered
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the relative outflow of [3H] in each subregion of both ex-
perimental groups, there was also a significant Group ef-
fect in the LS (F 1/7332.9, P0.001), the MS (F
1/7828.7, P0.001), and the DBB (F 1/7110.7,
P0.01).
Electrically-evoked overflow of tritium ([3H]ACh)
Data are shown in Fig. 5. ANOVA of the data from the
three septal subregions of SHAM rats showed a signif-
icant Subregion effect on the absolute (in nCi; Fig. 5A)
and the relative (in percent of [3H] accumulation; Fig. 5B)
overflow of tritium (F 2/10838.4 and 57.8, respectively,
P0.001). On the absolute and the relative overflow, as
substantiated by the N-K test, this effect was due to an
overflow which was significantly lower in the LS as com-
pared with both other subregions (P0.001), but also in
the MS as compared with the DBB (P0.001).
When ANOVA considered the absolute overflow of
[3H] in each subregion of both experimental groups (Fig.
5A), there was a significant Group effect in the LS (F
1/7365.4, P0.001), but neither in the MS (F 1/781.0),
nor in the DBB (F 1/711.0). In the LS, the absolute





























































Fig. 2. Mean (S.E.M.) ChAT (top) and AChE (bottom) activity in the hippocampus (left) and the frontoparietal cortex (right) in SHAM and SAPO-SPT
rats killed starting from 2 weeks after lesion surgery. Data are from five SHAM and five SAPO-SPT rats. Statistics: # indicates a significant effect of
the lesion as compared with SHAM, P0.05.
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sidered the relative overflow of [3H] in each subregion of
both experimental groups (Fig. 5B), there was a signifi-
cant Group effect in the LS (F 1/7395.7, P0.001), but
neither in the MS (F 1/781.0), nor in the DBB (F
1/711.2). In the LS, the relative overflow was reduced by
64%.
Effects of physostigmine and
physostigmineatropine
Fig. 6 shows that physostigmine reduced the evoked over-
flow of ACh in all three subregions of the septal area and
that the muscarinic antagonist atropine abolished this ef-
Table 1. AverageS.E.M. ChAT (nmol/mg prot./min) and AChE (nmoles/mg prot./min) activities in homogenates prepared from the LS, MS and DBB,
as well as from the frontoparietal cortex and the hippocampus of SHAM and SAPO-SPT rats 2 weeks after lesion surgery (separate set not used for
the superfusion experiments)a




SHAM SAPO-SPT SHAM SAPO-SPT
LS 0.410.02 0.290.05 13.182.53 14.926.21
MS 0.580.05 0.320.05# 24.113.02* 19.413.42
DBB 0.930.15*† 0.750.12 35.623.98*† 24.134.04
Frontoparietal cortex 0.430.07 0.200.36# 32.514.35 15.842.52#
Hippocampus 0.500.04 0.060.02# 44.754.57 4.770.58#
a The effects of intraseptal 192 IgG-saporin injections on the frontoparietal cortex and the hippocampus are shown as an account for appropriate
lesions of the cholinergic neurons of the septal region (compare values from the hippocampus and the cortex to values shown in Fig. 1). Statistics:
* significantly different from LS (analysis only in SHAM); † significantly different from MS (analysis only in SHAM); # significantly different from SHAM,
P0.01.
Fig. 3. Representative photomicrographs of sections through the MS (A,B), the vDBB (C,D) and the hDBB (E,F) showing ChAT-immunoreactive
neurons in a rat subjected to intraseptal injections of 192 IgG-saporin (B, D, F) as compared with a SHAM rat (A, C, E) killed 2 weeks after lesion
surgery. Scale bar50 m. The sections are slightly posterior to the injections sites.
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fect. This was confirmed statistically. A GroupDrug
ANOVA of the data collected in the presence of physostig-
mine showed a significant effect of physostigmine in each
subregion of the septal area (LS: F 1/6491.8; MS: F
1/75375.5 and DBB: F 1/711413.6; P0.001 in all
cases). Interestingly, when the data obtained in the pres-
ence of physostigmine were compared, the inhibitory effect
of physostigmine found in SAPO-SPT rats was signifi-
cantly smaller than in SHAM rats (P0.05), but only in the
LS. Analysis of the data collected in the presence of phy-
sostigmine and atropine also showed significant Drug ef-
fects in the MS and DBB, but only a tendency in the LS,
indicating that, in the presence of atropine, the physostig-
mine-induced inhibition of the overflow tended to be or was
more than counterbalanced; indeed, the evoked overflow
reached levels above controls (LS: F 1/633.4, P0.07;
MS: F 1/7436.8 and DBB: F 1/7141.7; P0.001 in both
last cases). None of these analyses showed a significant
GroupDrug interaction.
Concentration of monoamines
Data are shown in Table 4. ANOVA of the concentrations
of NA, DA, DOPAC, 5-HT and 5-HIAA, failed to show any
significant Group effect (ANOVA) in either the frontopari-
etal cortex or the hippocampus.
Table 2. Average numberS.E.M. of ChAT-positive neurons
(meanS.E.M.) counted at three levels from Bregma in the MS and
both the vertical (v) and horizontal (h) limbs of the DBB of rats sub-
jected to intraseptal injections of PBS or 192 IgG-saporin and killed 2
weeks after lesion surgerya
Level from
Bregma
SHAM SAPO Decrease in %
of control
MS
1.0 mm 19.501.32 5.251.65# 74%
0.6 mm 102.504.92 4.001.08# 96%
0.2 mm 59.255.36 9.001.58# 85%
vDBB
1.0 mm 23.251.89 4.001.35# 83%
0.6 mm 79.758.26 3.501.04# 96%
0.2 mm 35.500.87 4.250.47# 89%
hDBB
1.0 mm n.r. n.r. n.r.
0.6 mm 122.257.99 9.254.09# 92%
0.2 mm 84.006.12 9.504.33# 89%










































Fig. 4. Mean (S.E.M.) accumulation of [3H]choline in slices (indicated in pmol/slice) from the LS or MS and the DBB in SHAM and SAPO-SPT rats
killed starting from 2 weeks after lesion surgery. Data are from five SHAM and five SAPO-SPT rats. In SHAM * indicates a significant difference vs.
LS, and  a significant difference vs. MS, P0.05. # indicates a significant effect of the lesion within the septal subregion, P0.05.
Table 3. Absolute (in nCi) and relative (in % of [3H] accumulation)
baseline outflows of tritium in slices from the LS or MS and the DBB
preincubated with [3H]choline (meanS.E.M.)a
Septal
subregion
Baseline outflow SHAM SAPO-SPT
LS Absolute values in nCi 0.440.02 0.280.02#
Relative values in % of
[3H] accumulation
1.190.03 0.980.04#
MS Absolute values in nCi 0.710.02* 0.540.02#
Relative values in % of
[3H] accumulation
1.090.03 0.930.03#
DBB Absolute values in nCi 0.930.04*† 0.790.03#
Relative values in % of
[3H] accumulation
1.250.04† 1.060.03#
a Rats were SHAM or SAPO-SPT and killed starting from 2 weeks after
lesion surgery. Statistics: * significantly different from LS (analysis only
in SHAM); † significantly different from MS (analysis only in SHAM);
# significantly different from SHAM, P0.05. Data are from five SHAM
and five SAPO-SPT rats.
A. Birthelmer et al. / Neuroscience 122 (2003) 1059–1071 1065
DISCUSSION
The present results confirm that intraseptal injections of
the immunotoxin 192 IgG-saporin induce selective cholin-
ergic denervation of the hippocampus and, to a weaker
extent, of the cortex, as demonstrated by the reduction of
ChAT and AChE activity in these target structures of the
basal forebrain cholinergic system. The cholinergic nature
of the lesion was confirmed by immunostaining of ChAT-
positive neurons in the septal region (separate set of rats).
In contrast, monoaminergic systems were not affected.
The results also demonstrate that despite massive lesions
of p75NTR receptor-bearing cholinergic neurons in the sep-
tum and the DBB, the evoked overflow of acetylcholine
was reduced significantly only in the LS, and only weak or
non significant effects of 192 IgG-saporin were found on
ChAT and AChE activity in the septal region.
Heterogeneity between septal subregions
In the Disko et al. (1999) experiment, it was reported that the
evoked overflow of [3H]ACh followed an increasing dorso-
ventral gradient. The present data in SHAM rats confirmed
this report in terms of electrically-evoked release, ChAT
and AChE activity (see also Gould et al., 1991). Surpris-
ingly, in the present study, the accumulation of [3H]choline
by septal slices, which might be regarded as an indirect
marker for cholinergic function (see below) was only
slightly, though significantly, higher in the DBB as com-








































































Fig. 5. Electrically-evoked overflow of [3H]ACh in slices from the LS or MS and the DBB in SHAM and SAPO-SPT rats killed starting from 2 weeks
after lesion surgery. Data are from five SHAM and five SAPO-SPT rats. The overflow is shown as the mean (S.E.M.) of absolute (in nCi, top) or
relative (in percentage of tissue 3H, bottom) values. In SHAM * indicates a significant difference vs. LS, and  a significant difference vs. MS, P0.05;
# indicates a significant effect of the lesion within the septal subregion, P0.05.
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weaker difference is that, in the previous study by Disko et
al. (1999), part of the islands of Caleja and the olfactory
tubercles were comprised in the preparation of the DBB
(see Fig. 1 in Disko et al., 1999), whereas these two
regions, which are very rich in cholinergic terminals, were
removed from the DBB area in the present study. When
ChAT or AChE activity was considered, the DBB also
exhibited higher values as compared with both other
regions.
There are three, not necessarily exclusive possibili-
ties to account for the subregion-dependent differences
in the evoked ACh release, or activity of ChAT or AChE.
First, if the release involves intrinsic local terminals of
the septal cholinergic neurons bearing p75NTR receptors,
for instance collaterals of cholinergic neurons projecting to
the hippocampus, one might consider that the dorsoventral
gradient of the release would approximately follow the
amount of cholinergic neurons distributed along the dorso-
ventral axis of the septum: from a few or none in the LS
(e.g. Kimura et al., 1990), it would go to many in the MS
and even more in the DBB (e.g. Jakab and Leranth, 1995).
Second, if this release does not involve intrinsic cholinergic
neurons bearing p75NTR receptors, one might consider
that the extrinsic cholinergic innervation of the septal sub-
regions is low in the LS, and increases along the dorso-
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Fig. 6. Electrically-evoked overflow of [3H]ACh in the presence of 1 M physostigmine (top) or 1 M physostigmine1 M atropine (bottom) in SHAM
and SAPO-SPT rats killed starting from 2 weeks after lesion surgery. Data are from five SHAM and five SAPO-SPT rats. Means (S.E.M.) correspond
to the percentage of the corresponding controls (S2/S1 or S3/S1 ratios, i.e. no drug addition before S2 or S3). Statistics:
# significantly different from
SHAM, P0.05.
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sioned rats greatly favor this second possibility, at least
from a quantitative viewpoint. A third possibility would be
that of a bias due to differences in the size of the slices:
while small in the LS, they were larger in the MS and DBB,
and therefore the latter may have released a proportionally
larger quantity of neurotransmitter. However, while such
an explanation is compatible with the absolute release of
[3H]choline, it cannot at all apply to the release, as this
release is expressed as a ratio of the accumulated [3H].
The relative release thus accounts for differ-
ential densities of cholinergic terminals or for differential
regulations of release mechanisms in these terminals.
Overall, this conclusion is also partly substantiated by our
ChAT and AChE acitivity data in the three septal
subregions.
Effects of the lesions
Our results also largely confirm previous experiments
showing that intraseptal injections of 192 IgG-saporin in-
duce a massive cholinergic denervation of the hippocam-
pus. Unfortunately, we have only indirect evidence for the
extent of the cholinergic lesion in the septum of the rats
used for superfusion experiments, i.e. the reduced ChAT
or AChE activity in the hippocampus. We also know from
previous experiments that lesions such as the ones used
herein (same dose, same batch of 192 IgG-saporin) dra-
matically reduce the number of ChAT-positive neurons in
the MS and the DBB (Lehmann et al., 2003). Furthermore,
septal lesions made with even smaller amounts of this
immunotoxin reduce the evoked release of [3H]acetylcho-
line in hippocampal slices to almost nothing (Birthelmer et
al., 2002, 2003a). Finally, the data obtained from the rats
used for immunostaining of ChAT in the septal regions
confirmed that our cholinergic lesions were almost com-
plete in the MS and the DBB. The activity of ChAT and
AChE was also reduced in the LS, MS and DBB of SAPO-
SPT rats, though not significantly except for ChAT activity
in the MS, demonstrating that despite massive damage to
cholinergic neurons bearing p75NTR receptors, cholinergic
markers—most probably in axon terminals of cholinergic
neurons that do not bear these receptors—were not af-
fected in the three septal subregions as dramatically as in
the hippocampus. This observation is in line with an earlier
report by Ha¨ge et al. (1996) who showed that following
multiple intrahippocampal injections of 192 IgG-saporin,
the ChAT activity was reduced by about 85% in the hip-
pocampus, but only by 53% in the MS and 21% in the DBB.
Intraseptal injections of 192 IgG-saporin may also be
accompanied by some effects in the cortex. Although sep-
tal cholinergic neurons innervate some cortical areas (e.g.
Amaral and Kurz, 1985; Mesulam et al., 1983), part of this
cortical denervation was probably subsequent to diffusion
of the toxin to basalocortical neurons (e.g. Berger-
Sweeney et al., 1994; Heckers et al., 1994; Lehmann et al.,
2002a; Wrenn and Wiley, 1998). Our HPLC data show that
monoaminergic systems were not affected by the toxin,
confirming its high neurochemical selectivity.
There were also subregion-dependent effects of the
lesions on the accumulation of choline by the slices. Al-
though the tissue accumulation of [3H]choline certainly
resulted from both specific (by axon terminals) and non-
specific uptake or binding, or even incorporation into cell
membranes, part of it was certainly linked to the density of
cholinergic terminals, the functional state of the uptake
sites and/or the storage capacity of the cholinergic neu-
rons. This uptake was reduced in the LS after intraseptal
injections of 192 IgG-saporin, suggesting an alteration of
cholinergic processes in this subregion, although the re-
duction of ChAT activity (29%) was not significant, and
AChE activity was not affected. The presence of cholin-
ergic neurons in the LS is not clearly established (Bender
et al., 1996; Kimura et al., 1990), contrary to the MS and
the DBB. However cholinergic terminals have been de-
scribed in the LS (Bialowas and Frotscher, 1987; Kimura et
al., 1990) and, as part of them may arise from the MS (e.g.
Bialowas and Frotscher, 1987), the reduced uptake of
choline might be subsequent to damage of these cholin-
ergic neurons in the MS.
Origin of the ACh released within the septal region
In a previous article (Disko et al., 1999), several possibil-
ities have been raised to account for the electrically-
evoked release of acetylcholine by septal slices. These
included a release derived from i) the soma and dendrites
of the cholinergic neurons located in the septum and the
DBB, and which bear p75NTR receptors (i.e. somatoden-
dritic release, as described for dopaminergic neurons; e.g.
Cheramy et al., 1981; Geffen et al., 1976), ii) axonal col-
laterals of cholinergic projection neurons or a local network
of cholinergic neurons, which would be the same as in the
first proposal, and iii) terminals of extrinsic cholinergic
neurons, which do not bear p75NTR receptors. It was also
shown (Disko et al., 1999) that the evoked overflow of
Table 4. Concentration of monoamines (meanS.E.M. in ng/mg pro-
tein) in homogenates prepared from the frontoparietal cortex and the
hippocampus of SHAM and SAPO-SPT rats killed starting from 2


















a Statistics: there was no significant effect of the lesion. Data are from
five SHAM and five SAPO-SPT rats.
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acetylcholine in septal subregions could be inhibited by
application of a direct (oxotremorine) or an indirect (phy-
sostigmine) muscarinic agonist. As experimental evidence
from dual probe microdialysis suggested that cell bodies
and dendrites of cholinergic neurons of the septal region
do not possess muscarinic autoreceptors (Moor et al.,
1995), the possibility of a somatodendritic release of ace-
tylcholine was excluded and priority was given to that of a
release originating in nerve terminals of the axon collater-
als in this tissue (Disko et al., 1999). In an earlier study,
Consolo et al. (1990) have reported that acetylcholine
released in the basal forebrain originated in the pontomes-
encephalic tegmentum, but these authors did not pay par-
ticular attention to the septal region. Indeed, the ACh col-
lected by microdialysis was from the nucleus basalis, the
substantia innominata, the hDBB and the magnocellular
preoptic nucleus. If the ACh release observed in the septal
region also originates from neurons outside the septal
region, damage to intraseptal neurons that bear p75NTR
receptors by 192 IgG-saporin should not dramatically mod-
ify the release of acetylcholine in this region.
Our present results enable further discussion of this
issue. First, the occurrence of a somatodendritic release
originating in cholinergic septohippocampal projection
neurons expressing p75NTR receptors can probably be
excluded in the MS and the DBB, as a close-to-normal
release was still observed after massive damage of this
category of cholinergic neurons. There remains neverthe-
less a theoretical possibility that a significant amount of
cholinergic neurons expressing p75NTR receptors have
survived the lesion and that this population has taken up
[3H]choline and released [3H]acetylcholine in large
amounts (e.g. after upregulating adaptation). However, our
immunohistochemical data do not confirm this possibility.
In addition, the injections of 192 IgG-saporin reduced the
hippocampal ChAT activity by more than 90%, suggesting
that most of the cholinergic neurons innervating the hip-
pocampus were damaged, and it is not likely that the few
remaining ones accounted for the large and even close-to
normal amounts of [3H] released. Indirect evidence for this
comes from studies carried out on hippocampal slices
deprived of their cholinergic inputs and grafted with cell
suspensions containing grafts of septal neurons. Such
slices contain many cholinergic neurons but seldom do
more than compensate for the lesion-induced decrease of
electrically-evoked release of [3H]acetylcholine (e.g.
Birthelmer et al., 2002; Suhr et al., 1999). Therefore, it
seems reasonable to assume that at least part of the
release of acetylcholine reported previously in the MS and
the DBB (Disko et al., 1998, 1999) originated from extrinsic
afferents.
Now, the problem with these cholinergic afferents to
the septum concerns their origin. While many cholinergic
neurons from the pedunculopontine and the laterodorsal
tegmental nuclei project to the LS, no or only a few pro-
jections of these neurons were found in the MS and the
DBB according to Hallanger and Wainer (1988). This is at
some variance with an earlier report by Woolf and Butcher
(1986) who observed ChAT-positive (retrogradely labeled)
neurons that projected to the MS “primarily” in the dorso-
lateral tegmental nucleus, and a “very few such cells” were
found in the pedunculopontine tegmental nucleus. Thus
according to the literature, a few cholinergic terminals
present in the MS and the DBB of rats seem to originate
from neurons located in these brainstem structures, pri-
marily in the laterodorsal tegmental nucleus. An alternative
would be that this small amount of cholinergic cell bodies in
these brainstem nuclei causes a very dense cholinergic
innervation of the MS and the DBB. Another possible
source of this innervation is the LS. Hallanger and Wainer
(1988) have demonstrated that this septal subregion pro-
jected to the MS and the DBB, but they did not mention the
neurochemical identity of the fibers identified. If part of
these projections were cholinergic, they would probably
not arise from neurons expressing p75NTR receptors as, in
the present study, the release of [3H]acetylcholine was not
altered in the MS and the DBB of lesioned rats. Interest-
ingly, in a recent article, Naumann et al. (2002) used mice
with deletion of p75NTR receptors and reported that, in the
close vicinity of the LS, there was a population of cholin-
ergic neurons that were not stained by antibodies against
p75NTR receptors. Such neurons might also exist in rats
(Naumann, Anatomisches Institut I, University Freiburg,
Germany, personal communication) and might be potential
candidates for the innervation of the MS and the DBB,
even in rats injected with 192 IgG-saporin.
We also demonstrated that the terminals of the neu-
rons spared by the immunotoxin possessed muscarinic
autoreceptors, as the evoked release of acetylcholine was
inhibited by physostigmine, and this inhibition was re-
versed by the muscarinic antagonist atropine. This obser-
vation, which is in line with the report by Consolo et al.
(1990) or that by Disko et al. (1999), also means that the
description and discussion provided previously on the
postnatal development of muscarinic autoreceptors on
cholinergic terminals of the MS and the DBB (Disko et al.,
1998, 1999) concerns extrinsic or intrinsic septal cholin-
ergic neurons, but most probably not those bearing p75NTR
receptors.
Regarding the LS, the issue is not that clear, as we
found that the evoked release of acetylcholine was re-
duced by 192 IgG-saporin lesions. Only a few cholinergic
cell bodies have been described in this septal subregion
(Kimura et al., 1990) and a few cholinergic projections from
the MS to the LS have been found in a previous report.
Therefore we would like to propose that the reduced re-
lease in the LS might result from damage of the p75NTR
receptor-bearing cholinergic neurons located in the MS
and the DBB. The remaining part of the release in the LS
(not affected by the immunotoxin) might be from afferents
originating in the pedunculopontine and the laterodorsal
tegmentum (Hallanger and Wainer, 1988), or even from
intrinsic p75NTR receptor negative cholinergic neurons
(e.g. Naumann et al., 2002).
In conclusion, concerning the MS and the DBB, the
present data exclude the possibility that a significant
amount of acetylcholine released derives from intrinsic
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neurons bearing p75NTR receptors. Our data do however
not allow to decide, whether this release originated from
intrinsic cholinergic neurons that do not express p75NTR
receptors (for instance: within or close to the LS) or from
terminals of neurons located outside the septal region.
Whatever may be, a significant contribution of the cholin-
ergic neurons of the pedunculopontine and the laterodor-
sal nuclei seems questionable on the basis of the litera-
ture. For the LS, our data indicate that at least part of the
released acetylcholine originated from projections of cho-
linergic neurons that bear p75NTR receptors. Beside these
neurons, which might be located in the MS and the DBB,
the part of [3H]acetylcholine release that was not sensitive
to 192 IgG-saporin lesions might either involve cholinergic
afferents originating from the brainstem (laterodorsal and
pedunculopontine tegmentum) or intrinsic p75NTR recep-
tor-negative neurons. Further studies combining selective
lesions, various labeling techniques (e.g. retrograde), and
perhaps other methods to measure acetylcholine release
(e.g. in vivo microdialysis) should contribute to further clar-
ify this issue.
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